conmed
-
Financial
CONMED Given New $64.00 Price Target at Leerink Swann (CNMD)
CONMED (NASDAQ:CNMD) had its price target upped by Leerink Swann from $60.00 to $64.00 in a research note issued to investors on Tuesday.…
Read More » -
Financial
CONMED Earns Outperform Rating from Analysts at Northland Capital Partners (CNMD)
Northland Capital Partners started coverage on shares of CONMED (NASDAQ:CNMD) in a research report sent to investors on Friday morning. The firm issued…
Read More » -
Financial
CONMED Coverage Initiated at Northland Securities (CNMD)
By Mark Watkins Research analysts at Northland Securities initiated coverage on shares of CONMED (NASDAQ:CNMD) in a report released on…
Read More » -
Recon
CONMED Corporation Appoints Peter Shagory as Executive Vice President, Strategy and Corporate Development
CONMED Corporation Appoints Peter Shagory as Executive Vice President, Strategy and Corporate Development UTICA, N.Y.–(BUSINESS WIRE)–May 11, 2015– CONMED Corporation…
Read More » -
Recon
CONMED Corporation Appoints Peter Shagory as Executive Vice President, Strategy and Corporate Development
CONMED Corporation (NASDAQ:CNMD)today announced that it has appointed Peter Shagory as the Company’s Executive Vice President, Strategy and Corporate Development.…
Read More » -
Financial
CONMED Director Stephen Mandia Sells 3,899 Shares (CNMD)
CONMED (NASDAQ:CNMD) Director Stephen Mandia sold 3,899 shares of CONMED stock in a transaction that occurred on Thursday, April 30th. The shares were…
Read More » -
Financial
Analysts Set CONMED Target Price at $53.60 (NASDAQ:CNMD)
By Jim Brewer CONMED (NASDAQ:CNMD) has received a consensus recommendation of “Hold” from the seven brokerages that are presently covering the stock, StockRatingsNetwork reports.…
Read More » -
Financial
Ladenburg Thalmann Lowers CONMED to Neutral (CNMD)
Ladenburg Thalmann cut shares of CONMED (NASDAQ:CNMD) from a buy rating to a neutral rating in a research note issued to investors…
Read More » -
Financial
CONMED’s Hold Rating Reiterated at Piper Jaffray (CNMD)
By Zach Kirkland Piper Jaffray reiterated their hold rating on shares of CONMED (NASDAQ:CNMD) in a research report released on Thursday morning. Piper Jaffray currently…
Read More » -
Sports Medicine
CONMED Corporation Announces Leadership Transition
Joseph Corasanti Steps Down as CEO Founder Gene Corasanti Retires Independent Board Member Curt Hartman Appointed Interim CEO Charles Farkas…
Read More » -
CONMED Corporation Announces Board and Governance Changes
Jerome Lande and Curt Hartman Appointed to Board of Directors Mark Tryniski Appointed Chairman of the Board Coppersmith Capital Management Agrees…
Read More » -
Financial
ConMed Battles ‘Activist Investor’ Amid Harsh Quarter, Lowered Forecast
Vocal shareholder advocate Voce Capital demands some major overhauls at New York medtech company ConMed amid a tough quarter and…
Read More » -
CONMED Corporation Highlights New Products and Educational Offerings at the 2013 Annual American Academy of Orthopaedic Surgeons Meeting
UTICA, NEW YORK, Mar 19, 2013 (MARKETWIRE via COMTEX) — CONMED Corporation CNMD +3.06% is proud to announce an exciting…
Read More » -
CONMED Corporation Announces Second Quarter 2011 Financial Results
CONMED Corporation (NASDAQ: CNMD) today announced financial results for the second quarter of 2011. Sales for the second quarter…
Read More » -
CONMED Corporation Awarded Multiple Contracts With HealthTrust Purchasing Group
CONMED Corporation (NASDAQ: CNMD) announced today that HealthTrust Purchasing Group, LP (HealthTrust), a leading healthcare group purchasing organization, recently awarded…
Read More »